Oct. 16, 2012
/PRNewswire/ -- Philips Respironics, a unit of Royal Philips Electronics (NYSE: PHG, AEX: PHI), today at Medtrade 2012 showcases advancements that allow patients to sleep and breathe easier, demonstrating its commitment to improving the quality of life of those who suffer from chronic sleep and respiratory conditions. Medtrade, taking place this week at the Georgia World Congress Center, is the nation's largest conference and exposition focused exclusively on the home medical equipment (HME) industry.
At Medtrade 2012, Philips Respironics will offer homecare providers a first-hand look at solutions that treat and manage conditions that affect millions of Americans each year such as obstructive sleep apnea (OSA), chronic obstructive pulmonary disease (COPD) and asthma. Designed with the patient in mind, these new solutions bring quality care into the home, enabling those with sleep and respiratory conditions to maintain their freedom and independence. Philips Respironics will offer an interactive experience with multimedia displays, hands-on demonstrations and docent tours of its new products and programs.
"The role of the homecare provider has never been more critical," says
, senior vice president, general manager, Sleep and Respiratory Care, Philips Home Healthcare Solutions. "We are committed to helping homecare providers enhance patients' lives by delivering cost-effective solutions that drive better treatment, monitoring and management of their conditions. We are working together with all stakeholders to navigate through the changes in the new era of health care."
Some of the new offerings that Philips Respironics will be highlighting include:
- Fit for Life
specialized resupply mask solution
Fit for Life, a comprehensive mask and service program, gives providers a way to offer their patients easy and reliable access to important replacement masks, supplies and resources they need to benefit from their OSA therapy. It also offers simple ways for homecare providers to monitor and document compliance with major commercial and public insurance providers' eligibility requirements and the recently released Centers for Medicare and Medicaid Services' (CMS) resupply policy clarification.